AI assistant
Sending…
Arthur J. Gallagher & Co. — Director's Dealing 2021
Feb 24, 2021
29910_dirs_2021-02-24_a4a4f4ae-3431-42a5-99ad-b70395d47899.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Arthur J. Gallagher & Co. (AJG)
CIK: 0000354190
Period of Report: 2021-02-22
Reporting Person: GALLAGHER THOMAS JOSEPH (VICE PRESIDENT)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-22 | Common Stock | M | 27700 | $46.87 | Acquired | 296295 | Direct |
| 2021-02-22 | Common Stock | F | 17143 | $120.90 | Disposed | 279152 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-22 | Non-qualified Stock Option | $46.87 | M | 27700 | Disposed | 2021-03-12 | Common Stock (27700) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 96007 | Indirect |
| Common Stock | 66709 | Indirect |
| Common Stock | 31671 | Indirect |
| Common Stock | 55280 | Indirect |
| Common Stock | 121.1 | Indirect |
Footnotes
F1: The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
F2: These shares are held in trusts, for the benefit of the reporting person's children, of which his wife is a trustee.
F3: One-third of this stock option becomes exerciseable on each of the 3rd, 4th, and 5th anniversaries of the grant date.
More from Arthur J. Gallagher & Co.
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 24
Annual Report
2026
Mar 23
Regulatory Filings
2026
Mar 23